Physician profile
Katherine Koot
NPI 1790120913
$1,325.23
in general payments reported to CMS, 2019-2025
7 companies · $339 in 2025
The $339 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $69.46 · 2021: $19.96 · 2023: $477 · 2024: $420 · 2025: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $671 · Food and Beverage: $565.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $670.87 |
| Food and Beverage | $564.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $758.50 | 2023-2024 | Acell, Integra, Primatrix |
| Mimedx Group, INC. | $221.79 | 2025 | |
| Paratek Pharmaceuticals, INC. | $108.69 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $100.17 | 2020-2025 | Grafix Pl |
| Orthofix Medical, INC. | $74.25 | 2020-2024 | Physio-Stim |
| Zimmer Biomet Holdings, INC. | $46.60 | 2021-2023 | Subchondroplasty Knee Kit |
| Averitas Pharma INC. | $15.23 | 2025 | Qutenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Koot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.